Council Capital Adds Three, Promotes One
Healthcare private equity firm Council Capital has added three new hires. Geoff Crisanti has joined the firm as Value Creation Senior Associate, Harrison Johnson has joined as an Investment Associate, and Christian Ward has joined as Chief Financial Officer. In addition, the firm promoted Paul Lagarde from Associate to Senior Associate.
Crisanti will be focused on providing strategic and operational support to Council Capital's portfolio company executive teams. He was most recently with Aspire Health, where he drove strategic partnerships and led a direct-to-physician sales team.
Johnson will be focused on new investment evaluation, due diligence, and portfolio company support. Johnson joins Council Capital from Ernst & Young Capital Advisors (EYCA), where he worked in the Diversified Industrials Investment Banking group.
Ward will lead Council’s accounting, finance, and compliance functions; he brings more than a decade of private equity and audit experience with previous experience from Five Points Capital, Dixon Hughes Goodman LLP, and PWC.
Grant Jackson, Managing General Partner at Council Capital, said, “We are excited to welcome Geoff, Harrison, and Christian to our team, and to announce Paul’s promotion in recognition of his contributions to the firm since joining in 2018.” Grant continued, “We look forward to leveraging our CEO Council and growing team and resources to deepen our ability to partner with and grow companies on the right side of change in healthcare.”
Council Capital is actively investing from Council Capital IV, which closed at its hard cap of $200mn in November 2020.
© The Sortino Group Ltd
All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency or other Reprographic Rights Organisation, without the written permission of the publisher. For more information about reprints from AlphaWeek, click here.